KUSH PARMAR

CIK 1664281 · Co-CEO · last filed 2026-08-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$14.88M

Companies

10

Total Filings

56

Lifetime Open-Market Net

$5.67M

Filer Profile

Reported Address
C/O 5AM VENTURE MANAGEMENT, LLC
4 EMBARCADERO CENTER, SUITE 3110
SAN FRANCISCO, CA 94111
Related Filers
Andrew J. Schwab — 26 joint filings, latest 2026-08-12
5AM Opportunities I (GP), LLC — 20 joint filings, latest 2024-02-16
5AM Opportunities I, L.P. — 20 joint filings, latest 2024-02-16
5AM Partners VI, LLC — 17 joint filings, latest 2026-08-12
5AM Ventures VI, L.P. — 17 joint filings, latest 2026-08-12
SCOTT M ROCKLAGE — 16 joint filings, latest 2026-08-20
JOHN D DIEKMAN — 11 joint filings, latest 2026-08-20
5AM Opportunities II (GP), LLC — 9 joint filings, latest 2026-08-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRDA Director 1,093,313 $6.80 $7.43M $284.8K 12 2026-08-10
RLYB Director 297,371 $16.88 $5.02M $1.26M 11 2024-05-17
Akouos, Inc. (AKUS) Delisted Director 0 $13.29 $0 -$3.46M 5 2022-12-02
FIXX Director 26,880 $13.72 $368.8K -$37.36M 13 2022-06-17
VOR Director 88,332 $22.30 $1.97M $4.94M 3 2022-06-16
5:01 Acquisition Corp. (FVAM) Delisted Co-CEO 365,126 $10.00 $3.65M $0 4 2020-12-01
APRE 10%+ Owner 96,304 $0.77 $74.5K $40.00M 1 2019-10-09
ARVN Director 1,775 $8.45 $15.0K $0 3 2019-09-26
scPharmaceuticals Inc. (SCPH) Delisted Director $5.67 $0 1 2018-06-21
BOLD Director $2.83 $0 3 2018-06-08

Recent Filings · Page 2 of 6

56 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-06-12 TRDA Grant (A) $0 EDGAR
2023-05-19 RLYB Grant (A) $0 EDGAR
2023-03-09 RLYB Sell (S) −100,000 -$820.0K EDGAR
2023-01-05 RLYB Grant (A) $0 EDGAR
2022-12-02 Akouos, Inc. (AKUS) Delisted Mixed −4,135,786 $0 EDGAR
2022-06-27 Akouos, Inc. (AKUS) Delisted Grant (A) $0 EDGAR
2022-06-17 FIXX Grant (A) $0 EDGAR
2022-06-16 VOR Grant (A) $0 EDGAR
2022-06-07 RLYB Sell (S) −150,000 -$1.88M EDGAR
2022-06-06 TRDA Grant (A) $0 EDGAR
Showing 1120 of 56
Page 2 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.